Science Explorer Interactive view Map
Company · Exton · United States

Morphotek (United States)

morphotek.comROR OpenAlex
Research works
66
▼ 74% vs 2013–17
Citations
2k
30.2 per fractional work
Top-10% rate
23.6%
record average 16.5%
Open access
43%
world 28%

Not ranked overall: Morphotek (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

    Who are the top researchers at Morphotek (United States)?

    Ranked on the composite score, Nicholas C. Nicolaides, Daniel J. O’Shannessy and Luigi Grasso lead among researchers whose main affiliation is Morphotek (United States).

    1. 1 Nicholas C. Nicolaides United States · #64,853 worldwide 345 citations · 38 works
    2. 2 Daniel J. O’Shannessy United States · #673,516 worldwide 48 citations · 15 works
    3. 3 Luigi Grasso United States · #948,846 worldwide 82 citations · 23 works
    4. 4 Katherine A. Rybinski United States · #1,341,241 worldwide 14 citations · 20 works
    All ranked researchers at Morphotek (United States)

    Which keywords describe research at Morphotek (United States)?

    By fractional works in all years, weighted toward what it does more of than the world: Glycosylation, Monoclonal Antibodies, Therapeutic Antibodies, Cancer, Antibody Engineering, Fc Receptors, Immunotherapy and Angiogenesis.

    ▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

    Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

    All 40 words, with their numbers
    1. Glycosylation10▲ 72×3 topics
    2. Monoclonal Antibodies9▲ 95×3 topics
    3. Therapeutic Antibodies8▲ 101×2 topics
    4. Antibody Engineering8▲ 113×1 topic
    5. Cancer8▲ 8.1×13 topics
    6. Fc Receptors8▲ 113×1 topic
    7. Immunotherapy7▲ 16×7 topics
    8. Angiogenesis6▲ 24×7 topics
    9. Chemotherapy6▲ 13×7 topics
    10. Breast Cancer5▲ 27×5 topics
    11. Tumor Regression5▲ 86×2 topics
    12. Inflammation5▲ 3.1×12 topics
    13. Monoclonal Antibody5▲ 99×2 topics
    14. Tumor Targeting5▲ 53×3 topics
    15. Gene Therapy4▲ 25×2 topics
    16. Cancer Therapy4▲ 10×8 topics
    17. Metastasis4▲ 19×6 topics
    18. Arginine Deprivation4▲ 141×1 topic
    19. Bacterial Therapy4▲ 141×1 topic
    20. HER24▲ 182×1 topic
    21. Trastuzumab4▲ 129×1 topic
    22. Targeted Therapy3▲ 24×3 topics
    23. Tumor Suppression3▲ 45×2 topics
    24. Clinical Trials3▲ 7.4×3 topics
    25. Autoimmunity3▲ 20×2 topics
    26. Endothelial Dysfunction3▲ 15×2 topics
    27. Regulation3▲ 6.9×3 topics
    28. Folate3▲ 100×1 topic
    29. Homocysteine3▲ 100×1 topic
    30. Apoptosis2▲ 9.7×3 topics
    31. Biopharmaceuticals2▲ 56×3 topics
    32. Fibrosis2▲ 19×2 topics
    33. PET Imaging2▲ 17×4 topics
    34. Tumor Microenvironment2▲ 10×7 topics
    35. Cell Cycle2▲ 60×1 topic
    36. Cytoreductive Surgery2▲ 52×2 topics
    37. Immune Regulation2▲ 27×2 topics
    38. Immune System2▲ 11×2 topics
    39. Therapeutics2▲ 24×2 topics
    40. p532▲ 80×1 topic

    Which research topics does Morphotek (United States) publish most on?

    By volume: Monoclonal and Polyclonal Antibodies Research, Cancer Research and Treatments, HER2/EGFR in Cancer Research and Folate and B Vitamins Research.

    Monoclonal and Polyclona…8Monoclonal and Polyclonal Antibodies Research: 8 fractional worksCancer Research and Treatments: 4 fractional worksHER2/EGFR in Cancer Research: 4 fractional worksFolate and B Vitamins Research: 3 fractional worksCancer-related Molecular Pathways: 2 fractional worksGalectins and Cancer Biology: 2 fractional worksGlycosylation and Glycoproteins Research: 2 fractional worksOvarian cancer diagnosis and treatment: 2 fractional worksCancer Cells and Metastasis: 2 fractional worksAngiogenesis and VEGF in Cancer: 2 fractional works
    Radiology, Nuclear Medicine and ImagingBiotechnologyOncologyRheumatology3 others

    Area is fractional works; colour is the subfield each topic belongs to.

    1. 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 8 works
    2. 2 Cancer Research and Treatments Biotechnology 4 works
    3. 3 HER2/EGFR in Cancer Research Oncology 4 works
    4. 4 Folate and B Vitamins Research Rheumatology 3 works
    5. 5 Cancer-related Molecular Pathways Oncology 2 works
    6. 6 Galectins and Cancer Biology Immunology 2 works
    7. 7 Glycosylation and Glycoproteins Research Molecular Biology 2 works
    8. 8 Ovarian cancer diagnosis and treatment Reproductive Medicine 2 works
    9. 9 Cancer Cells and Metastasis Oncology 2 works
    10. 10 Angiogenesis and VEGF in Cancer Molecular Biology 2 works

    How open and international is its research?

    Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

    openly available42.8%not open57.2%

    World: 28% of research is openly available.

    with international co-authors11.5%domestic only88.5%

    World: 19% is written across borders.

    How has Morphotek (United States)'s research output changed?

    Output in 2018–2022 was 74% lower than in 2013–2017.

    200520102015
    grewheldshrank

    The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

    Other research institutions in Exton

    All research institutions in Exton

    Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.